2-hydroxy-4-methylvaleric acidWhat was measured
Measured, with no finding
79 endpoints
Show what was measuredHide what was measured
fat mass
no effect
while fat mass remained constant
PMID 20051111 · one of two readings recorded this
hemoglobin
The average value for the total subject group was 150 ± 6.4 g/l in hemoglobin and 44 ± 0.03 in hematocrit
PMID 20051111 · one of two readings recorded this
20 m sprint
no effect
20 m (s) | 3.02 ± 0.06 | 3.04 ± 0.11 | 2.96 ± 0.05 | 2.98 ± 0.06
PMID 20051111 · one of two readings recorded this
400 m run
no effect
400 m (s) | 61.3 ± 1.8 | 61.7 ± 1.6 | 60.2 ± 1.7 | 59.1 ± 0.7
PMID 20051111 · one of two readings recorded this
5-jump
no effect
5-jump (m) | 13.44 ± 0.71 | 13.80 ± 0.73 | 13.22 ± 0.70 | 13.63 ± 0.91
PMID 20051111 · one of two readings recorded this
bench press 1RM
no effect
Bench press 1RM (kg) | 87.5 ± 21.0 | 87.9 ± 20.9 | 82.5 ± 13.5 | 83.3 ± 14.6
PMID 20051111 · one of two readings recorded this
body composition of upper extremities
no effect
There were no differences between the groups in body composition of upper extremities
PMID 20051111 · one of two readings recorded this
body weight
increases, p = 0.005
The difference between the treatments was significant in body weight (p < 0.005)
PMID 20051111 · one of two readings recorded this
body weight
Body weight was in the HICA group before and after the 4-week study period 72.6 ± 9.1 kg and 72.9 ± 8.6 kg and in the PLACEBO group 70.0 ± 5.2 kg and 70.1 ± 5.1 kg, respectively
PMID 20051111 · one of two readings recorded this
body weight
Body weight was in the HICA group before and after the 4-week study period 72.6 ± 9.1 kg and 72.9 ± 8.6 kg and in the PLACEBO group 70.0 ± 5.2 kg and 70.1 ± 5.1 kg, respectively
PMID 20051111 · one of two readings recorded this
bone mass
no effect
Also bone mass (3.6 ± 0.1 kg) remained constant in both groups
PMID 20051111 · one of two readings recorded this
countermovement jump (CMJ)
no effect
CMJ (m) | 43.5 ± 0.03 | 42.8 ± 0.06 | 42.3 ± 0.06 | 44.2 ± 0.05
PMID 20051111 · one of two readings recorded this
dietary carbohydrate intake
energy 11183 ± 2361 kJ, protein 119 ± 37 g, carbohydrate 341 ± 87 g, and fat 82 ± 23 g
PMID 20051111 · one of two readings recorded this
dietary energy intake
energy 11183 ± 2361 kJ, protein 119 ± 37 g, carbohydrate 341 ± 87 g, and fat 82 ± 23 g
PMID 20051111 · one of two readings recorded this
dietary fat intake
energy 11183 ± 2361 kJ, protein 119 ± 37 g, carbohydrate 341 ± 87 g, and fat 82 ± 23 g
PMID 20051111 · one of two readings recorded this
dietary protein intake
energy 11183 ± 2361 kJ, protein 119 ± 37 g, carbohydrate 341 ± 87 g, and fat 82 ± 23 g
PMID 20051111 · one of two readings recorded this
full squat 1RM
no effect
Full squat 1RM (kg) | 120 ± 19 | 130 ± 24 | 131 ± 29 | 138 ± 16
PMID 20051111 · one of two readings recorded this
hematocrit (group comparison)
no effect
There were no differences in hemoglobin or hematocrit between the groups of HICA and PLACEBO or between before and after measurements in each group
PMID 20051111 · one of two readings recorded this
hematocrit
The average value for the total subject group was 150 ± 6.4 g/l in hemoglobin and 44 ± 0.03 in hematocrit
PMID 20051111 · one of two readings recorded this
hemoglobin (group comparison)
no effect
There were no differences in hemoglobin or hematocrit between the groups of HICA and PLACEBO or between before and after measurements in each group
PMID 20051111 · one of two readings recorded this
lactate after 400 m run
no effect
lactate (mmol/l) a | 13.6 ± 1.3 | 14.5 ± 2.2 | 14.4 ± 2.8 | 14.2 ± 2.9
PMID 20051111 · one of two readings recorded this
lean body mass of lower extremities, DXA regional
increases, 400 g increase in HICA versus 150 g decrease in PLACEBO, p = 0.01
Not recorded as a finding: Regional lean mass is a subgroup of the whole-body lean-mass node (node is whole-body FFM); no node for the lower-extremity compartment.
The lean body mass of lower extremities increased by 400 g in the HICA group but decreased by 150 g in the PLACEBO group and the changes between the groups differed significantly (p < 0.01).
PMID 20051111 · one of two readings recorded this
lean body mass of lower extremities (treatment difference)
increases, p = 0.05
The difference between the treatments was significant also in lean body mass of lower extremities (p < 0.05)
PMID 20051111 · one of two readings recorded this
lean body mass of lower extremities
increases, p = 0.01
The lean body mass of lower extremities increased by 400 g in the HICA group but decreased by 150 g in the PLACEBO group and the changes between the groups differed significantly (p < 0.01)
PMID 20051111 · one of two readings recorded this
matches during study
The training amount across the study period consisted of 13 ± 3 soccer sessions, 4 ± 1 strength training sessions and 3 ± 1 matches
PMID 20051111 · one of two readings recorded this
performance variables, including bench press 1RM, full squat 1RM and countermovement jump (CMJ), field tests
no effect, no significant differences between groups in any variable
Not recorded as a finding: The only two-sided sentence says 'any of the variables' and never names 1RM or CMJ, so no object span exists inside the quote; the figures sit in a table.
There were no significant differences between the groups HICA and PLACEBO in any of the variables.
PMID 20051111 · one of two readings recorded this
pH after 400 m run
no effect
pH a | 7.09 ± 0.11 | 7.17 ± 0.12 | 7.12 ± 0.12 | 7.17 ± 0.12
PMID 20051111 · one of two readings recorded this
soccer sessions during study
The training amount across the study period consisted of 13 ± 3 soccer sessions, 4 ± 1 strength training sessions and 3 ± 1 matches
PMID 20051111 · one of two readings recorded this
strength endurance (row after bench press)
no effect
Strength endurance (reps) | 31 ± 3 | 32 ± 4 | 28 ± 2 | 31 ± 3
PMID 20051111 · one of two readings recorded this
strength endurance (row after full squat)
no effect
Strength endurance (reps) | 31 ± 8 | 47 ± 5 | 36 ± 10 | 38 ± 11
PMID 20051111 · one of two readings recorded this
strength training sessions during study
The training amount across the study period consisted of 13 ± 3 soccer sessions, 4 ± 1 strength training sessions and 3 ± 1 matches
PMID 20051111 · one of two readings recorded this
training alertness (week 1)
no effect
Training alertness was during every study week slightly better in the HICA group (3.6 ± 0.5; 4.2 ± 0.5; 4.1 ± 0.5; 4.3 ± 0.6) compared to the PLACEBO group (3.3 ± 0.6; 3.0 ± 0.9; 3.4 ± 1.1; 3.4 ± 0.8) but significantly (p < 0.05) better only in the second week
PMID 20051111 · one of two readings recorded this
training alertness (week 2)
increases, p = 0.05
Training alertness was during every study week slightly better in the HICA group (3.6 ± 0.5; 4.2 ± 0.5; 4.1 ± 0.5; 4.3 ± 0.6) compared to the PLACEBO group (3.3 ± 0.6; 3.0 ± 0.9; 3.4 ± 1.1; 3.4 ± 0.8) but significantly (p < 0.05) better only in the second week
PMID 20051111 · one of two readings recorded this
training alertness (week 3)
no effect
Training alertness was during every study week slightly better in the HICA group (3.6 ± 0.5; 4.2 ± 0.5; 4.1 ± 0.5; 4.3 ± 0.6) compared to the PLACEBO group (3.3 ± 0.6; 3.0 ± 0.9; 3.4 ± 1.1; 3.4 ± 0.8) but significantly (p < 0.05) better only in the second week
PMID 20051111 · one of two readings recorded this
training alertness (week 4)
no effect
Training alertness was during every study week slightly better in the HICA group (3.6 ± 0.5; 4.2 ± 0.5; 4.1 ± 0.5; 4.3 ± 0.6) compared to the PLACEBO group (3.3 ± 0.6; 3.0 ± 0.9; 3.4 ± 1.1; 3.4 ± 0.8) but significantly (p < 0.05) better only in the second week
PMID 20051111 · one of two readings recorded this
whole body DOMS
no effect
all weeks 1.5 ± 0.3 for HICA and 1.7 ± 0.4 for PLACEBO
PMID 20051111 · one of two readings recorded this
whole body DOMS
decreases, p = 0.05
The HICA supplementation decreased significantly (p < 0.05) the whole body DOMS symptoms only in the 4th week of the treatment (1.4 ± 0.3) when compared to placebo (1.8 ± 0.2)
PMID 20051111 · one of two readings recorded this
whole lean body mass
increases, p = 0.05
LBM: before 62.2 ± 6.7 and after 62.5 ± 6.5 for HICA and before 62.2 ± 4.9 and after 62.2 ± 4.6 for PLACEBO; p < 0.05
PMID 20051111 · one of two readings recorded this
all outcomes (between-group and time-group interaction)
no effect
No significant between-group or time-group interactions were observed
PMID 30102677 · one of two readings recorded this
cortisol (time effect)
modulates, p = 0.001
Time-dependent changes were observed for muscle thickness (P < 0.001), one repetition maximum bench press and squat (P < 0.001), Wingate peak power (P = 0.02), countermovement jump height (P = 0.03), power (P = 0.006), creatine kinase, insulin-like growth factor-1, growth hormone, and cortisol (all P < 0.001)
PMID 30102677 · one of two readings recorded this
countermovement jump height (time effect)
modulates, p = 0.03
Time-dependent changes were observed for muscle thickness (P < 0.001), one repetition maximum bench press and squat (P < 0.001), Wingate peak power (P = 0.02), countermovement jump height (P = 0.03), power (P = 0.006), creatine kinase, insulin-like growth factor-1, growth hormone, and cortisol (all P < 0.001)
PMID 30102677 · one of two readings recorded this
creatine kinase (time effect)
modulates, p = 0.001
Time-dependent changes were observed for muscle thickness (P < 0.001), one repetition maximum bench press and squat (P < 0.001), Wingate peak power (P = 0.02), countermovement jump height (P = 0.03), power (P = 0.006), creatine kinase, insulin-like growth factor-1, growth hormone, and cortisol (all P < 0.001)
PMID 30102677 · one of two readings recorded this
ergogenic effect on any outcome variable
no effect
No leucine metabolite resulted in any ergogenic effects on any outcome variable
PMID 30102677 · one of two readings recorded this
fat-free mass at baseline
α-HICA (n = 10, fat-free mass [FFM] = 62.0 ± 7.1 kg)
PMID 30102677 · one of two readings recorded this
fat-free mass at baseline
HMB-Ca (n = 9, FFM = 65.6 ± 10.1 kg)
PMID 30102677 · one of two readings recorded this
fat-free mass at baseline
HMB-FA (n = 11, FFM = 62.7 ± 10.5 kg)
PMID 30102677 · one of two readings recorded this
fat-free mass at baseline
placebo (PLA; n = 10, FFM = 64.2 ± 5.7 kg)
PMID 30102677 · one of two readings recorded this
growth hormone (time effect)
modulates, p = 0.001
Time-dependent changes were observed for muscle thickness (P < 0.001), one repetition maximum bench press and squat (P < 0.001), Wingate peak power (P = 0.02), countermovement jump height (P = 0.03), power (P = 0.006), creatine kinase, insulin-like growth factor-1, growth hormone, and cortisol (all P < 0.001)
PMID 30102677 · one of two readings recorded this
insulin-like growth factor-1 (time effect)
modulates, p = 0.001
Time-dependent changes were observed for muscle thickness (P < 0.001), one repetition maximum bench press and squat (P < 0.001), Wingate peak power (P = 0.02), countermovement jump height (P = 0.03), power (P = 0.006), creatine kinase, insulin-like growth factor-1, growth hormone, and cortisol (all P < 0.001)
PMID 30102677 · one of two readings recorded this
muscle thickness by ultrasound; one repetition maximum bench press and squat; Wingate peak power; countermovement jump height; creatine kinase, IGF-1, growth hormone, cortisol, total testosterone
no effect, no significant between-group or time-group interactions
Not recorded as a finding: the supporting sentence never names the compound
No significant between-group or time-group interactions were observed.
PMID 30102677 · one of two readings recorded this
muscle thickness (time effect)
increases, p = 0.001
Time-dependent changes were observed for muscle thickness (P < 0.001), one repetition maximum bench press and squat (P < 0.001), Wingate peak power (P = 0.02), countermovement jump height (P = 0.03), power (P = 0.006), creatine kinase, insulin-like growth factor-1, growth hormone, and cortisol (all P < 0.001)
PMID 30102677 · one of two readings recorded this
one repetition maximum bench press and squat (time effect)
increases, p = 0.001
Time-dependent changes were observed for muscle thickness (P < 0.001), one repetition maximum bench press and squat (P < 0.001), Wingate peak power (P = 0.02), countermovement jump height (P = 0.03), power (P = 0.006), creatine kinase, insulin-like growth factor-1, growth hormone, and cortisol (all P < 0.001)
PMID 30102677 · one of two readings recorded this
power (time effect)
modulates, p = 0.006
Time-dependent changes were observed for muscle thickness (P < 0.001), one repetition maximum bench press and squat (P < 0.001), Wingate peak power (P = 0.02), countermovement jump height (P = 0.03), power (P = 0.006), creatine kinase, insulin-like growth factor-1, growth hormone, and cortisol (all P < 0.001)
PMID 30102677 · one of two readings recorded this
Wingate peak power (time effect)
modulates, p = 0.02
Time-dependent changes were observed for muscle thickness (P < 0.001), one repetition maximum bench press and squat (P < 0.001), Wingate peak power (P = 0.02), countermovement jump height (P = 0.03), power (P = 0.006), creatine kinase, insulin-like growth factor-1, growth hormone, and cortisol (all P < 0.001)
PMID 30102677 · one of two readings recorded this
Body composition (DXA and BIS total body water)
no effect
No statistically significant between-group or group-by-time interactions were observed
PMID 30588860 · one of two readings recorded this
Fat-free mass
n = 40
α-HICA (n = 10, fat-free mass [FFM] = 62.0 ± 7.1 kg), HMB-FA (n = 11, FFM = 62.7 ± 10.5 kg), HMB-Ca (n = 9, FFM = 65.6 ± 10.1 kg) or placebo (PLA; n = 10, FFM = 64.2 ± 5.7 kg)
PMID 30588860 · one of two readings recorded this
Trunk fat-free mass
increases, p = 0.05
Time-dependent changes were observed for increase in trunk FFM (p < 0.05)
PMID 30588860 · one of two readings recorded this
1RM back squat change
no effect
back squat: α-HICA, 18.5% ± 18.9%; HMB-FA, 23.2% ± 16%; HMB-Ca, 10.5% ± 13.8%; PLA, 19.7% ± 9%
PMID 31079555 · one of two readings recorded this
1RM bench press change
no effect, p = 0.001
bench press: α-HICA, 13.8% ± 19.1%; HMB-FA, 15.5% ± 9.3%; HMB-Ca, 10% ± 10.4%; PLA, 14.4 ± 11.3%, both p < 0.001
PMID 31079555 · one of two readings recorded this
all outcomes (between-group comparison)
no effect
No differences were found between groups at any time point
PMID 31079555 · one of two readings recorded this
association of circulating inflammatory markers with change in outcomes
no effect
backwards elimination regressions showed that no circulating inflammatory marker consistently shared variance with the change in any outcome
PMID 31079555 · one of two readings recorded this
fat-free mass at baseline
α-hydroxyisocaproic acid group ([α-HICA], n = 10, Fat-free mass [FFM] = 62.0 ± 7.1 kg)
PMID 31079555 · one of two readings recorded this
fat-free mass at baseline
calcium β-hydroxy-β-methylbutyrate group ([HMB-Ca], n = 9, FFM = 65.6 ± 10.1 kg)
PMID 31079555 · one of two readings recorded this
fat-free mass at baseline
β-hydroxy-β-methylbutyrate free acid group ([HMB-FA], n = 11, FFM = 62.7 ± 10.5 kg)
PMID 31079555 · one of two readings recorded this
fat-free mass at baseline
placebo group ([PLA]; n = 10, FFM = 64.2 ± 5.7 kg)
PMID 31079555 · one of two readings recorded this
high-sensitivity C-reactive protein (time effect)
increases, p = 0.001
IL-6, hsCRP (both p < 0.001) and TNF-α (p = 0.045)
PMID 31079555 · one of two readings recorded this
interleukin-6, high-sensitivity C-reactive protein and tumour necrosis factor alpha, assessed at baseline and weeks 4 and 8
no effect, no differences between groups at any time point
Not recorded as a finding: the supporting sentence never names the compound
No differences were found between groups at any time point.
PMID 31079555 · one of two readings recorded this
interleukin-6 (time effect)
increases, p = 0.001
IL-6, hsCRP (both p < 0.001) and TNF-α (p = 0.045)
PMID 31079555 · one of two readings recorded this
muscle thickness, rectus femoris (time effect)
increases, p = 0.018
Time-dependent increases were detected from baseline to week 8 for MT (vastus lateralis: p = 0.009; rectus femoris: p = 0.018)
PMID 31079555 · one of two readings recorded this
muscle thickness, vastus lateralis (time effect)
increases, p = 0.009
Time-dependent increases were detected from baseline to week 8 for MT (vastus lateralis: p = 0.009; rectus femoris: p = 0.018)
PMID 31079555 · one of two readings recorded this
training-induced inflammation (IL-6, hsCRP, TNF-α)
no effect
No leucine metabolite attenuated inflammation during training
PMID 31079555 · one of two readings recorded this
tumour necrosis factor alpha (time effect)
increases, p = 0.045
IL-6, hsCRP (both p < 0.001) and TNF-α (p = 0.045)
PMID 31079555 · one of two readings recorded this
1-repetition maximum for back squat and bench press; phase angle and bioimpedance vector analysis patterns; fat-free mass and fat mass by DXA
no effect, no group by time interactions
Not recorded as a finding: the supporting sentence never names the compound
Leucine metabolites have no effect on PhA, BIVA patterns or strength during an 8-week resistance training program, in resistance trained subjects.
PMID 33337947 · one of two readings recorded this
1RM back squat (time effect)
increases
time-dependent increases were observed for 1RM back squat and 1RM bench press
PMID 33337947 · one of two readings recorded this
1RM bench press (time effect)
increases
time-dependent increases were observed for 1RM back squat and 1RM bench press
PMID 33337947 · one of two readings recorded this
association of phase angle with 1RM bench press change
increases
A direct association was observed between PhA and 1RM bench press changes (whole sample)
PMID 33337947 · one of two readings recorded this
phase angle and bioimpedance vector (time course)
no effect
PhA and vector did not change over the training period
PMID 33337947 · one of two readings recorded this
phase angle, BIVA patterns and strength (leucine metabolite effect)
no effect
Leucine metabolites have no effect on PhA, BIVA patterns or strength during an 8-week resistance training program, in resistance trained subjects
PMID 33337947 · one of two readings recorded this
phase angle (group by time interaction)
no effect
No statistically group by time interactions were found, even adjusting for age
PMID 33337947 · one of two readings recorded this